PHENY-PAS-TEBAMIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pheny-pas-tebamin, and when can generic versions of Pheny-pas-tebamin launch?
Pheny-pas-tebamin is a drug marketed by Pharm Res Assoc and is included in one NDA.
The generic ingredient in PHENY-PAS-TEBAMIN is phenyl aminosalicylate. There is one drug master file entry for this compound. Additional details are available on the phenyl aminosalicylate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PHENY-PAS-TEBAMIN?
- What are the global sales for PHENY-PAS-TEBAMIN?
- What is Average Wholesale Price for PHENY-PAS-TEBAMIN?
Summary for PHENY-PAS-TEBAMIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 54 |
| Patent Applications: | 769 |
| DailyMed Link: | PHENY-PAS-TEBAMIN at DailyMed |
US Patents and Regulatory Information for PHENY-PAS-TEBAMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharm Res Assoc | PHENY-PAS-TEBAMIN | phenyl aminosalicylate | POWDER;ORAL | 011695-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharm Res Assoc | PHENY-PAS-TEBAMIN | phenyl aminosalicylate | TABLET;ORAL | 011695-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
